Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study - Annals of Oncology
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer | NEJM
Cancers | Free Full-Text | Adjuvant Chemotherapy for Stage III Colon Cancer
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial - ScienceDirect
Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 / NO16966, a randomized phase III trial in first-line metastatic. - ppt video online download
Adjuvant treatment for colon cancer. | Download Scientific Diagram
Median cycle of XELOX adjuvant chemotherapy received by patients for... | Download Scientific Diagram
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline | Journal of Clinical Oncology
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer | NEJM
PPT - ESMO/ECCO Presidential Session III PowerPoint Presentation, free download - ID:5764158
Figure 2 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
Kaplan–Meier curves of patients with stage III colon cancer in right-... | Download Scientific Diagram
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer | British Journal of Cancer
Adjuvant Therapy for Locoregional Colon Cancer (Slides With Transcript)
Adjuvant chemotherapy for colorectal cancer - ScienceDirect
Metachronous pulmonary and pancreatic metastases arising from sigmoid colon cancer: A case report
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - The Lancet Oncology
4. Cancer colorectal métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results | British Journal of Cancer
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials - ScienceDirect
